Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema [PDF]
American Journal of Ophthalmology Case Reports, 2018 Purpose: To report the efficacy and safety of interferon alpha 2b in the treatment of pseudophakic cystoid macular edema resistant to conventional therapy.
Arash Maleki, Hossein Aghaei, Stacey Lee
doaj +5 more sources
Drug-Loaded Hydrogels for Intraocular Lenses with Prophylactic Action against Pseudophakic Cystoid Macular Edema [PDF]
Pharmaceutics, 2021 Pseudophakic cystoid macular edema (PCME), caused by chronic inflammation, is the most common cause of visual impairment in the medium-term after cataract surgery. Therefore, the prophylactic topical administration of combined steroidal and non-steroidal
Nadia Toffoletto +5 more
doaj +3 more sources
Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac. [PDF]
J Clin Med, 2020 Background: To evaluate the clinical course of pseudophakic cystoid macular edema (PCME) treated with topical non-steroidal anti-inflammatory drugs (NSAIDs).
Aaronson A, Achiron A, Tuuminen R.
europepmc +6 more sources
Commentary: An option for treating resistant pseudophakic cystoid macular edema [PDF]
Indian Journal of Ophthalmology, 2021 Mahesh Shanmugam Palanivelu
doaj +4 more sources
Systemic immune-inflammation index could be associated with pseudophakic cystoid macular edema after an uneventful phacoemulsification surgery in patients without risk factors. [PDF]
BMC Ophthalmol, 2022 Background To evaluate the association between serum biomarkers and pseudophakic cystoid macular edema (PCME) in eyes without risk factors after uneventful phacoemulsification cataract surgery. Methods This is a case–control study.
Kocamış Sİ, Boz AAE, Özdemir İ.
europepmc +2 more sources
Efficacy of Intravitreal Injection of Filtered Modified Low-Dose Triamcinolone Acetonide and Ranibizumab on Pseudophakic Cystoid Macular Edema. [PDF]
Front Med (Lausanne), 2022 Purpose To compare the visual and morphological effects between intravitreal injection of filtered modified 2 mg triamcinolone acetonide (TA) and 0. 5 mg ranibizumab in patients with pseudophakic cystoid macular edema (PCME).
Tariq F +5 more
europepmc +2 more sources
Pseudophakic Cystoid Macular Edema [PDF]
Ophthalmologica, 2011 Cataract surgery is an efficient procedure, and is generally associated with good visual results. Nevertheless, cystoid macular edema (CME) may develop, and this can result in suboptimal postoperative vision.
Lobo, C
core +5 more sources
Comparative outcomes of posterior sub-Tenon triamcinolone for pseudophakic cystoid macular edema in diabetic and non-diabetic patients: a retrospective study. [PDF]
BMC OphthalmolPurpose To compare the anatomical and functional outcomes of posterior sub-Tenon triamcinolone (PST) in the treatment of pseudophakic cystoid macular edema (PCME) between diabetic and non-diabetic patients.
Demir K, Çelik E.
europepmc +2 more sources
Treatment modalities of pseudophakic cystoid macular edema
TNOA Journal of Ophthalmic Science and Research, 2023 Purpose: To evaluate the clinical profile of cystoid macular edema (CME) following cataract extraction and to assess the response to various treatment modalities.
Hariharasubramanian Kasthuribai +3 more
semanticscholar +2 more sources
Pathophysiology of transient corneal edema and pseudophakic cystoid macular edema. [PDF]
Korean J Ophthalmol, 2015 Dear Editor, We read with interest the article titled "Transient corneal edema is a predictive factor for pseudophakic cystoid macular edema after uncomplicated cataract surgery" [1], in which the authors found that transient corneal edema (TCE) following cataract surgery is a predictive factor of pseudophakic cystoid macular edema (PCME). The study
Han SB, Kim M, Lee SJ, Yang HK.
europepmc +4 more sources